Light modulation with optimal power energy: new dry eye treatment for upper and lower eyelids
Eye-light® is comprehensive solution featuring dual, complementary technologies, Light Modulation® LLLT and Optimal Power Energy®(OPE) IPL, for an optimal, non-invasive treatment of most ocular surface conditions from Dry Eye Disease (DED) induced by Meibomian Glands Dysfunction (MGD) to Sjögren’s Syndrome.
Optimal Power Energy®: The best IPL on the market.
OPE® IPL is the patented Intense Pulsed Light technology in eye-light. OPE® is designed as a polychromatic light whose thermal impulses are calibrated through software to always be emitted at just the right intensity, providing an extremely high degree of safety and effectiveness.
OPE® IPL is the only pulsed light in the world allowing for usage without any protective gel. This is made possible by our patented, software-enabled technology providing a light impulse that’s emitted at just the right frequency, every time, throughout every beam. This provides both operators and patients with an invaluable asset: the convenience of an exceptional, frictionless experience.
About Light Modulation ® LLLT
Eye-light’s patented photobiomodulation technology solicits cells’ mitochondria, triggering biochemical and biophysical reactions that stimulate them to a better protein synthesis as well as generating endogenous heat through increased ATP generation. Thanks to the near-infrared emission of light, the tear lipid layer is increased and stabilized. On top of the Red Light LLLT, eye-light® also features Blue and Yellow LM® LLLT technology to administer the photobiostimulation therapy for most ocular surface diseases.
LLLT can be safely performed on all patients independent of skin pigmentation and directly treats the eyelids and the periocular area.
Together eye-light’s OPE IPL and LLLT Provide Incremental Benefits
Eye-light’s dual therapy surpasses the efficacy of IPL or RF monotherapy. Together these modalities combine to provide exceptional treatment responses.